Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROaR+: Raltegravir vs. Ritonavir-boosted Darunavir Lipid Effects in HIV
NCT01258439Phase 4Completed
- Sponsor
- St Vincent's Hospital
- Start
- Nov 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by St Vincent's Hospital. Started Nov 2010; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01258439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01258439.